BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 31293600)

  • 1. Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review.
    Edwards G; Diercks GFH; Seelen MAJ; Horvath B; van Doorn MBA; Damman J
    Front Immunol; 2019; 10():1477. PubMed ID: 31293600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
    Chan LS; Cooper KD
    Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of autoimmune blistering diseases: the Pemphigoid diseases.
    Daniel BS; Murrell DF
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1685-1694. PubMed ID: 31087464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bullous autoimmune dermatoses of the mucous membranes].
    Didona D; Hinterseher J; Eming R
    Dermatologie (Heidelb); 2022 Sep; 73(9):692-700. PubMed ID: 36006424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subepithelial autoimmune blistering dermatoses: Clinical features and diagnosis.
    Montagnon CM; Tolkachjov SN; Murrell DF; Camilleri MJ; Lehman JS
    J Am Acad Dermatol; 2021 Jul; 85(1):1-14. PubMed ID: 33684496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blistering diseases in the mature patient.
    Lakoš Jukić I; Jerković Gulin S; Marinović B
    Clin Dermatol; 2018; 36(2):231-238. PubMed ID: 29566927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies.
    Chan LS; Traczyk T; Taylor TB; Eramo LR; Woodley DT; Zone JJ
    Arch Dermatol; 1995 Dec; 131(12):1432-7. PubMed ID: 7492134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone.
    Zillikens D; Kawahara Y; Ishiko A; Shimizu H; Mayer J; Rank CV; Liu Z; Giudice GJ; Tran HH; Marinkovich MP; Bröcker EB; Hashimoto T
    J Invest Dermatol; 1996 Mar; 106(3):465-70. PubMed ID: 8648178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models to investigate pathomechanisms and evaluate novel treatments for autoimmune bullous dermatoses.
    Iwata H; Bieber K; Hirose M; Ludwig RJ
    Curr Pharm Des; 2015; 21(18):2422-39. PubMed ID: 25777758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subepithelial autoimmune bullous dermatoses disease activity assessment and therapy.
    Montagnon CM; Lehman JS; Murrell DF; Camilleri MJ; Tolkachjov SN
    J Am Acad Dermatol; 2021 Jul; 85(1):18-27. PubMed ID: 33684494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of autoimmune bullous diseases in Middle Franconia.
    Sollfrank L; Schönfelder V; Sticherling M
    Front Immunol; 2023; 14():1256617. PubMed ID: 37881435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune blistering dermatoses as systemic diseases.
    Vassileva S; Drenovska K; Manuelyan K
    Clin Dermatol; 2014; 32(3):364-75. PubMed ID: 24767184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional heterogeneity of immune complexes in epidermolysis bullosa acquisita.
    Gammon WR; Briggaman RA
    J Invest Dermatol; 1987 Nov; 89(5):478-83. PubMed ID: 3668292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basement membrane reactivity of antisera to type IV collagen and sera from patients with bullous pemphigoid and epidermolysis bullosa acquisita.
    Peng TK; Nisengard RJ; Levine MJ; Beutner EH
    Proc Natl Sci Counc Repub China B; 1984 Jul; 8(3):268-73. PubMed ID: 6400590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune bullous dermatoses.
    Cunha PR; Barraviera SR
    An Bras Dermatol; 2009; 84(2):111-24. PubMed ID: 19503978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses.
    Jenkins RE; Rodenas J; Bhogal BS; Black MM
    Dermatology; 1994; 189 Suppl 1():133-4. PubMed ID: 8049556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutrition and bullous diseases.
    Stoj V; Lu J
    Clin Dermatol; 2022; 40(2):156-165. PubMed ID: 34808244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human skin basement membrane in health and in autoimmune diseases.
    Chan LS
    Front Biosci; 1997 Jul; 2():d343-52. PubMed ID: 9232815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biological aspects of acquired bullous diseases.
    Dabelsteen E
    Crit Rev Oral Biol Med; 1998; 9(2):162-78. PubMed ID: 9603234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoimmune bullous skin disorders].
    Hertl M; Niedermeier A; Borradori L
    Ther Umsch; 2010 Sep; 67(9):465-82. PubMed ID: 20806175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.